Tricyclic antidepressants target FKBP51 SUMOylation to restore glucocorticoid receptor activity
The DOI matches its Crossref record; the references it cites are not checked yet.
Abstract
FKBP51 is an important inhibitor of the glucocorticoid receptor (GR) signaling. High FKBP51 levels are associated to stress-related disorders, which are linked to GR resistance. SUMO conjugation to FKBP51 is necessary for FKBP51's inhibitory action on GR. The GR/FKBP51 pathway is target of antidepressant action. Thus we investigated if these drugs could inhibit FKBP51 SUMOylation and therefore restore GR activity. Screening cells using Ni 2+ affinity and in vitro SUMOylation assays revealed that tricyclic antidepressants- particularly clomipramine- inhibited FKBP51 SUMOylation. Our data show that clomipramine binds to FKBP51 inhibiting its interaction with PIAS4 and therefore hindering its SUMOylation. The inhibition of FKBP51 SUMOylation decreased its binding to Hsp90 and GR facilitating FKBP52 recruitment, and enhancing GR activity. Reduction of PIAS4 expression in rat primary astrocytes impaired FKBP51 interaction with GR, while clomipramine could no longer exert its inhibitory action. This mechanism was verified in vivo in mice treated with clomipramine. These results describe the action of antidepressants as repressors of FKBP51 SUMOylation as a molecular switch for restoring GR sensitivity, thereby providing new potential routes of antidepressant intervention.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Another study demonstrated that FKBP51, a crucial modulator of the glucocorticoid receptor (GR) pathway, can bind to clomipramine and impede its interaction with PIAS4. Inhibition of this interaction subsequently hinders sumoylation; this alteration represents a newly discovered mechanism by which the antidepressant drug exerts its effect. 356”
From Major depressive disorder: hypothesis, mechanism, prevention and treatment (2024) · cites this paper as [356]
Citations
The citation lists are queued
They are fetched later and appear here then.
References 87 · Cited by 17
Metadata
- Authors
- Budziñski, M. L., Sokn, C., Gobbini, R., Ugo, B., Antunica-Noguerol, M., Senin, S., Bajaj, T., Gassen, N. C., Rein, T., Schmidt, M. V., Binder, E. B., Arzt, E., & Liberman, A. C.
- Affiliations
- Max Planck Society (DE)
- University of Bonn (DE)
- Max Planck Institute of Psychiatry (DE)
- Corresponding author
- Arzt, Eduardo
- Liberman, Ana C.
- ORCID
- Venue
- Molecular Psychiatry
- Published
- 2022-03-08
- Volume
- 27
- Issue
- 5
- Pages
- 2533-2545
- ISSN
- 1359-4184 (ISSN-L)
- 1476-5578
- OpenAlex
- W4220857785
- Cited by
- 17
- References
- 87
- Citations by year
- 2026: 1 · 2025: 4 · 2024: 5 · 2023: 2 · 2022: 5
- FWCI
- 2.36
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Molecular Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- MPG.PuRe (Max Planck Society) (submittedVersion)
- Funders
- Agencia Nacional de Promoción Científica y Tecnológica, Argentina
- Bundesministerium für Bildung und Forschung (01EE1401D)
- “OptiMD” grant of the Federal Ministry of Education and Research Germany
- Max Planck Society, Germany; University of Buenos Aires; CONICET; Agencia Nacional de Promoción Científica y Tecnológica, Argentina; and FOCEM-Mercosur
- Topics
- Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Endocrinology › Estrogen and related hormone effects
- Keywords
- tricyclic antidepressants, clomipramine, FKBP51, SUMOylation, glucocorticoid receptor, PIAS4, HSP90, FKBP52, glucocorticoid resistance, stress-related disorders, astrocytes, antidepressant mechanism
- MeSH terms
- Animals, Antidepressive Agents, Tricyclic, Clomipramine, Gene Expression Regulation, Receptors, Glucocorticoid, Tacrolimus Binding Proteins, Mice, Rats, Sumoylation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Tricyclic antidepressants target FKBP51 SUMOylation to restore glucocorticoid receptor activity. https://app.cochat.ai/papers/10.1038/s41380-022-01491-0
- The paper
- Budziñski, M. L., Sokn, C., Gobbini, R., Ugo, B., Antunica-Noguerol, M., Senin, S., Bajaj, T., Gassen, N. C., Rein, T., Schmidt, M. V., Binder, E. B., Arzt, E., & Liberman, A. C. (2022). Tricyclic antidepressants target FKBP51 SUMOylation to restore glucocorticoid receptor activity. Molecular Psychiatry. https://doi.org/10.1038/s41380-022-01491-0
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.